Trichosporon asahii and Candida guilliermondii as a Source of Orbital Infection in an Immunocompromised Individual
A 47-year-old male with a history of immunosuppression and recent intensive care unit admission presented with progressive orbital swelling and pain. Blood cultures grew <i>Trichosporon asahii</i> and <i>Candida guilliermondii</i>, with matching positive cultures from peripheral and central venous samples. Given his fungemia and worsening orbital involvement, induction therapy with amphotericin B and isavuconazole was initiated. Within weeks, clinical improvement was noted, prompting a transition to long-term consolidation therapy with oral posaconazole and isavuconazole. At follow-up, the patient demonstrated sustained clinical stability with no recurrence of infection. Orbital involvement from fungemia due to <i>T. asahii</i> and <i>C. guilliermondii</i> is rare, and management requires early recognition, aggressive antifungal therapy, and careful monitoring.
Authors
- John Foxworth
- M. Schill
- Katie Hardy
- David Morcos
- Anthony Makovec
Institutions
- Truman Medical Center (US)
- Louisiana State University Health Sciences Center New Orleans (US)
- University of Missouri–Kansas City (US)
Publication Details
- Journal
- Cureus
- Published
- 2025-02-15
- DOI
- https://doi.org/10.7759/cureus.79062
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00